Identification of changes in gene expression associated with minimal residual disease

Ruey Ho Kao, Maria Von Schlippe, Giulio Francia, Jill Powell, Ian R. Hart

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Minimal residual disease (MRD), the tumour burden which remains after a course of treatment that has resulted in clinical remission [1], appears to differ in certain characteristics from the primary tumour population. Certainly the cells which comprise MRD have had to escape from the constraints of the primary tumour mass, invade normal tissue and penetrate small vessels in order to enter the circulation in which they then have had to survive. Such activities are the consequence of the expression of specific proteins and these may well be a reflection of alterations in DNA or RNA levels. Identifying the changes in RNA expression levels between related cell groups exhibiting different phenotypes recently has become a great deal easier as a consequence of developments in analytical procedures such as Differential Display (DD) and Serial Analysis of Gene Expression (SAGE). Application of these procedures to MRD cells recovered from blood, bone marrow or lymph node, should identify novel sequences associated with tumour progression and the development of disseminated disease.

Original languageEnglish
Pages (from-to)3-13
Number of pages11
JournalCancer and Metastasis Reviews
Volume18
Issue number1
DOIs
Publication statusPublished - Sep 8 1999
Externally publishedYes

Fingerprint

Residual Neoplasm
Gene Expression
RNA
Neoplasms
Tumor Burden
Blood Cells
Lymph Nodes
Bone Marrow
Phenotype
DNA
Population
Proteins

Keywords

  • Gene expression
  • Metastasis
  • Minimal residual disease

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Identification of changes in gene expression associated with minimal residual disease. / Kao, Ruey Ho; Von Schlippe, Maria; Francia, Giulio; Powell, Jill; Hart, Ian R.

In: Cancer and Metastasis Reviews, Vol. 18, No. 1, 08.09.1999, p. 3-13.

Research output: Contribution to journalArticle

Kao, Ruey Ho ; Von Schlippe, Maria ; Francia, Giulio ; Powell, Jill ; Hart, Ian R. / Identification of changes in gene expression associated with minimal residual disease. In: Cancer and Metastasis Reviews. 1999 ; Vol. 18, No. 1. pp. 3-13.
@article{2ef9c573a39b419d8e65f3d842b10cee,
title = "Identification of changes in gene expression associated with minimal residual disease",
abstract = "Minimal residual disease (MRD), the tumour burden which remains after a course of treatment that has resulted in clinical remission [1], appears to differ in certain characteristics from the primary tumour population. Certainly the cells which comprise MRD have had to escape from the constraints of the primary tumour mass, invade normal tissue and penetrate small vessels in order to enter the circulation in which they then have had to survive. Such activities are the consequence of the expression of specific proteins and these may well be a reflection of alterations in DNA or RNA levels. Identifying the changes in RNA expression levels between related cell groups exhibiting different phenotypes recently has become a great deal easier as a consequence of developments in analytical procedures such as Differential Display (DD) and Serial Analysis of Gene Expression (SAGE). Application of these procedures to MRD cells recovered from blood, bone marrow or lymph node, should identify novel sequences associated with tumour progression and the development of disseminated disease.",
keywords = "Gene expression, Metastasis, Minimal residual disease",
author = "Kao, {Ruey Ho} and {Von Schlippe}, Maria and Giulio Francia and Jill Powell and Hart, {Ian R.}",
year = "1999",
month = "9",
day = "8",
doi = "10.1023/A:1006243917187",
language = "English",
volume = "18",
pages = "3--13",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Identification of changes in gene expression associated with minimal residual disease

AU - Kao, Ruey Ho

AU - Von Schlippe, Maria

AU - Francia, Giulio

AU - Powell, Jill

AU - Hart, Ian R.

PY - 1999/9/8

Y1 - 1999/9/8

N2 - Minimal residual disease (MRD), the tumour burden which remains after a course of treatment that has resulted in clinical remission [1], appears to differ in certain characteristics from the primary tumour population. Certainly the cells which comprise MRD have had to escape from the constraints of the primary tumour mass, invade normal tissue and penetrate small vessels in order to enter the circulation in which they then have had to survive. Such activities are the consequence of the expression of specific proteins and these may well be a reflection of alterations in DNA or RNA levels. Identifying the changes in RNA expression levels between related cell groups exhibiting different phenotypes recently has become a great deal easier as a consequence of developments in analytical procedures such as Differential Display (DD) and Serial Analysis of Gene Expression (SAGE). Application of these procedures to MRD cells recovered from blood, bone marrow or lymph node, should identify novel sequences associated with tumour progression and the development of disseminated disease.

AB - Minimal residual disease (MRD), the tumour burden which remains after a course of treatment that has resulted in clinical remission [1], appears to differ in certain characteristics from the primary tumour population. Certainly the cells which comprise MRD have had to escape from the constraints of the primary tumour mass, invade normal tissue and penetrate small vessels in order to enter the circulation in which they then have had to survive. Such activities are the consequence of the expression of specific proteins and these may well be a reflection of alterations in DNA or RNA levels. Identifying the changes in RNA expression levels between related cell groups exhibiting different phenotypes recently has become a great deal easier as a consequence of developments in analytical procedures such as Differential Display (DD) and Serial Analysis of Gene Expression (SAGE). Application of these procedures to MRD cells recovered from blood, bone marrow or lymph node, should identify novel sequences associated with tumour progression and the development of disseminated disease.

KW - Gene expression

KW - Metastasis

KW - Minimal residual disease

UR - http://www.scopus.com/inward/record.url?scp=0032824585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032824585&partnerID=8YFLogxK

U2 - 10.1023/A:1006243917187

DO - 10.1023/A:1006243917187

M3 - Article

C2 - 10505542

AN - SCOPUS:0032824585

VL - 18

SP - 3

EP - 13

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 1

ER -